(MedPage Today) — ORLANDO — Patients with newly diagnosed chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) lived significantly longer without disease progression when treated with the Bruton’s tyrosine kinase (BTK) inhibitor…
Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118905
Author :
Publish date : 2025-12-09 15:30:00
Copyright for syndicated content belongs to the linked Source.
